Biosynthesis of Enkephalin Opioid Peptides
脑啡肽阿片肽的生物合成
基本信息
- 批准号:7241534
- 负责人:
- 金额:$ 29.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-01-01 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationActive SitesAdrenal GlandsAdrenal MedullaAffinityAffinity LabelsAftercareAminopeptidaseAnabolismAnalgesicsAntisense OligonucleotidesArginineBasic Amino AcidsBehaviorBiochemicalBiological AssayBos taurusBrainCathepsin LCattleCell physiologyCellsChemicalsChromaffin CellsChromaffin granuleCleaved cellCompatibleComplementComplementary DNAComplexConditionCysteine ProteaseCytoplasmic GranulesDataDrug or chemical Tissue DistributionDynorphinsEndopeptidasesEndorphinsEnkephalinsEnzymesEvaluationExcisionFamilyFundingGel ChromatographyGene SilencingGoalsImmuneImmune SeraImmunoelectron MicroscopyIn VitroKineticsKnock-outKnockout MiceKnowledgeLocalizedLysineMammalian CellMass Spectrum AnalysisMediatingMethionine EnkephalinMicroscopyMolecularMolecular CloningN-terminalNeuroendocrine CellNeuronsNeuropeptidesNeurosecretory SystemsOpioidOpioid PeptidePC12 CellsPainPathway interactionsPeptide HydrolasesPeptidesPersonal SatisfactionPhysiologic pulsePlasmid Cloning VectorPlasmidsProcessProductionProhormone ConvertasePropertyProprotein Convertase 1Proprotein Convertase 2Protein PrecursorsProteinsProteolytic ProcessingPulse takingRadioimmunoassayRattusRecombinantsRegulationRelative (related person)RodentRoleSecretory VesiclesSiteSpecificitySubstrate SpecificitySubtilisinSubtilisinsSystemTestingTimeTissuesVacciniaVaccinia virusViralWestern Blottingaffinity labelingaminopeptidase Barginyllysinebasebrain tissuecarboxypeptidase Hendogenous opioidsenkephalin degrading enzymeenzyme activityin vivoinhibitor/antagonistinterestmRNA Expressionmemberproenkephalinprohormone thiol proteaseprotein aminoacid sequenceprotein expression
项目摘要
DESCRIPTION (provided by applicant): Proteolytic processing of proenkephalin (PE) is required to produce active enkephalin opioid peptides that regulate analgesia, behavior, and immune cell function. It is, therefore, critical to define the multi-step proteolytic pathway required to convert PE into active enkephalin peptides. Our studies of PE processing have identified the cysteine protease termed 'prohormone thiol protease' (PTP) as the major PE cleaving activity in enkephalin-containing chromaffin granules. Notably, recent progress on this continuing project utilized active site affinity labeling and peptide microsequencing by mass spectrometry to identify the responsible PTP activity as cathepsin L. Cathepsin L is colocalized in secretory vesicles with enkephalin, and cathepsin L cleaves enkephalin-containing substrates at identical cleavage sites as native PTP. Significantly, cathepsin L knockout mice show reduced levels of enkephalin in brain. These new results implicate a key role for secretory vesicle cathepsin L in enkephalin peptide production. The cleavage specificities of cathepsin L and PTP generate peptide intermediates with NH2-terminal basic residue extensions. These findings indicate that Arg/Lys aminopeptidase is then necessary to remove such basic residues. Indeed, Arg/Lys aminopeptidase activity is colocalized in chromaffin granules with PE, enkephalin, and PTP/cathepsin L. These new discoveries of cathepsin L and Arg/Lys aminopeptidase enyzmes for PE processing complement our earlier findings showing participation of the subtilisin-like PC1 and PC2 and carboxypeptidase E/H in processing PE. These findings provide the basis for the goal of this proposal that will investigate the roles of secretory vesicle cathepsin L and Arg/Lys aminopeptidase, with PC1 and PC2, in the proteolytie pathway required for processing PE into enkephalin opioid peptides. This goal will be achieved in four specific aims, which will (1) evaluate PE processing by (a) determining the relative efficiency and cleavage sites for in vitro processing of PE by secretory vesicle cathepsin L, compared to PC1 and PC2, and (b) assessing cellular PE processing during enzyme coexpression with PE in PC12 cells, (2) assess the colocalization of cathepsin L with enkephalin and PC enzymes in chromaffin cells, transfected PC12 cells, and rat brain and neuroendocrine tissues, (3) examine the effects of reduced enzyme activity on PE processing in (a) chromaffin cells and cortical neurons subjected to antisense enzyme expression, as well as direct inhibition of cathepsin L with a selective chemical inhibitor, and in (b) cathepsin L knockout and PC2 knockout mice that show reduced enkephalin levels in brain, and (4) obtain biochemical and molecular analyses of Arg/Lys aminopeptidase for enkephalin production. Results can establish functional roles for two new protease components, secretory vesicle cathepsin L and Arg/Lys aminopeptidase, in the biosynthesis of enkephalin opioid peptides. These findings will enhance our knowledge of the complexity of the endogenous opioid system.
描述(由申请人提供):需要对前脑啡肽(proenkephalin, PE)进行蛋白水解处理,以生产调节镇痛、行为和免疫细胞功能的活性脑啡肽类阿片肽。因此,确定将PE转化为活性脑啡肽所需的多步骤蛋白水解途径至关重要。我们对PE加工的研究已经确定了半胱氨酸蛋白酶称为“激素原硫醇蛋白酶”(PTP)是含脑啡肽的染色质颗粒中主要的PE切割活性。值得注意的是,这个持续项目的最新进展利用活性位点亲和标记和肽微测序的质谱鉴定了PTP的活性与组织蛋白酶L有关。组织蛋白酶L与脑啡肽共定位在分泌囊泡中,组织蛋白酶L在与天然PTP相同的切割位点上切割含有脑啡肽的底物。值得注意的是,组织蛋白酶L敲除小鼠显示脑啡肽水平降低。这些新的结果暗示了分泌囊泡组织蛋白酶L在脑啡肽产生中的关键作用。组织蛋白酶L和PTP的切割特性产生具有nh2末端碱性残基延伸的肽中间体。这些发现表明精氨酸/赖氨酸氨基肽酶是去除这些碱性残基所必需的。事实上,精氨酸/赖氨酸氨基肽酶活性在染色质颗粒中与PE、脑啡肽和PTP/组织蛋白酶L共定位。这些组织蛋白酶L和精氨酸/赖氨酸氨基肽酶参与PE加工的新发现补充了我们先前的发现,即枯草杆菌样PC1和PC2以及羧肽酶E/H参与PE加工。这些发现为研究分泌囊泡组织蛋白酶L和精氨酸/赖氨酸氨基肽酶以及PC1和PC2在将PE加工成脑啡肽类阿片肽所需的蛋白水解途径中的作用提供了基础。这一目标将通过四个具体目标来实现,即:(1)通过(a)确定与PC1和PC2相比,分泌囊泡组织蛋白酶L在体外处理PE的相对效率和切割位点来评估PE加工,(b)评估PC12细胞中与PE酶共表达时的细胞PE加工,(2)评估组织蛋白酶L与脑啡肽和PC酶在染色质细胞、转染的PC12细胞和大鼠脑和神经内分泌组织中的共定位。(3)检测酶活性降低对(a)受反义酶表达的染色质细胞和皮质神经元PE加工的影响,以及选择性化学抑制剂对组织蛋白酶L的直接抑制,以及(b)组织蛋白酶L敲除和PC2敲除显示脑啡肽水平降低的小鼠,以及(4)获得脑啡肽产生的精氨酸/赖氨酸氨基肽酶的生化和分子分析。结果表明,分泌囊泡组织蛋白酶L和精氨酸/赖氨酸氨基肽酶两种新的蛋白酶组分在脑啡肽类阿片肽的生物合成中具有功能作用。这些发现将增强我们对内源性阿片系统复杂性的认识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vivian Y. H Hook其他文献
Vivian Y. H Hook的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vivian Y. H Hook', 18)}}的其他基金
Development of Molecular Probe Inhibitors of Pathogenic, Cytosolic Cathespin B in Traumatic Brain Injury and Alzheimers Disease Neurodegeneration
外伤性脑损伤和阿尔茨海默病神经变性中致病性胞质组织蛋白酶 B 的分子探针抑制剂的开发
- 批准号:
10451837 - 财政年份:2019
- 资助金额:
$ 29.3万 - 项目类别:
Development of molecular probe inhibitors of pathogenic, cytosolic cathespin B in traumatic brain injury and Alzheimers Disease neurodegeneration
开发创伤性脑损伤和阿尔茨海默病神经变性中致病性胞质组织蛋白酶 B 的分子探针抑制剂
- 批准号:
10199079 - 财政年份:2019
- 资助金额:
$ 29.3万 - 项目类别:
Development of Molecular Probe Inhibitors of Pathogenic, Cytosolic Cathespin B in Traumatic Brain Injury and Alzheimers Disease Neurodegeneration
外伤性脑损伤和阿尔茨海默病神经变性中致病性胞质组织蛋白酶 B 的分子探针抑制剂的开发
- 批准号:
10652388 - 财政年份:2019
- 资助金额:
$ 29.3万 - 项目类别:
Role of Human-Specific Cathepsin V Protease in the Production of Opioid and Related Peptide Neurotransmitters
人类特异性组织蛋白酶 V 蛋白酶在阿片类药物和相关肽神经递质生产中的作用
- 批准号:
9215425 - 财政年份:2015
- 资助金额:
$ 29.3万 - 项目类别:
Role of Human-Specific Cathepsin V Protease in the Production of Opioid and Related Peptide Neurotransmitters
人类特异性组织蛋白酶 V 蛋白酶在阿片类药物和相关肽神经递质生产中的作用
- 批准号:
9007800 - 财政年份:2015
- 资助金额:
$ 29.3万 - 项目类别:
Aminopeptidases for Neurotoxic Pyroglutamate Beta-Amyloid of Alzheimers Disease
氨基肽酶治疗阿尔茨海默病的神经毒性焦谷氨酸β-淀粉样蛋白
- 批准号:
8583849 - 财政年份:2013
- 资助金额:
$ 29.3万 - 项目类别:
Aminopeptidases for Neurotoxic Pyroglutamate Beta-Amyloid of Alzheimers Disease
氨基肽酶治疗阿尔茨海默病的神经毒性焦谷氨酸β-淀粉样蛋白
- 批准号:
8690732 - 财政年份:2013
- 资助金额:
$ 29.3万 - 项目类别:
Proteolytic Fragments of Mutant Huntingtin Protein in HD Brain Regions
HD 脑区突变亨廷顿蛋白的蛋白水解片段
- 批准号:
8073938 - 财政年份:2010
- 资助金额:
$ 29.3万 - 项目类别:
Proteolytic Fragments of Mutant Huntingtin Protein in HD Brain Regions
HD 脑区突变亨廷顿蛋白的蛋白水解片段
- 批准号:
7991243 - 财政年份:2010
- 资助金额:
$ 29.3万 - 项目类别:
Prohormone processing: NPY and Catestatin Peptide Production
激素原加工:NPY 和儿联蛋白肽生产
- 批准号:
7844954 - 财政年份:2009
- 资助金额:
$ 29.3万 - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 29.3万 - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 29.3万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 29.3万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 29.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 29.3万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 29.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 29.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 29.3万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 29.3万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 29.3万 - 项目类别:
Discovery Grants Program - Individual